GOCOVRI 68.5 mg/1

GOCOVRI 68.5 mg/1 is a coated pellet capsule containing amantadine, used for managing symptoms of certain neurological conditions. This medication is designed for oral administration and is manufactured by Supernus Pharmaceuticals in the USA.

GOCOVRI 68.5 mg/1 is primarily used to help manage symptoms associated with specific neurological disorders. Amantadine, the active ingredient, is often prescribed to alleviate symptoms such as stiffness, shakiness, and difficulty moving. Patients may wonder, 'What is GOCOVRI used for?' This medication is typically used as part of a broader treatment plan for conditions that affect movement and coordination.

Common effects of GOCOVRI 68.5 mg/1 may include dizziness, dry mouth, and constipation. Some users might experience blurred vision or nausea. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

GOCOVRI 68.5 mg/1 should be handled with care, especially for individuals with a history of certain medical conditions. It's advisable to consult a healthcare provider before starting this medication, particularly if there are pre-existing conditions or allergies. Always follow the prescribed guidelines for safe usage.

GOCOVRI 68.5 mg/1 may interact with other medications, including those that affect the central nervous system. Alcohol and certain over-the-counter drugs can also influence its effectiveness. It's important to inform a healthcare provider about all medications being taken to avoid potential interactions.